Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Allied Healthcare Group Changes Name To Admedus Limited

Allied Healthcare Group (ASX: AHZ) will change its name to Admedus Limited with effect from 25 November 2013 as the company continues to build revenue growth in key markets.

This includes the expansion of its CardioCel® regenerative tissue repair product for repairing and reconstructing heart defects as well as results from the Phase 1 clinical trial of its herpes therapeutic vaccine.

CardioCel has recently received its first European sale and is awaiting approval for marketing to begin in the U.S.

Meanwhile, the Phase 1 trial looks set to achieve its key objective, which is to determine the safety of the vaccine. Interim results are anticipated towards the end of 2013 / early 2014 with full results in mid-2014.

All other corporate details, including the company's ASX code, remain unchanged.

Proactive Investors Australia is the market leader in producing news, articles and research reports on ASX "Small and Mid-cap" stocks with distribution in Australia, UK, North America and Hong Kong / China.